Vitamin D insufficiency and insulin resistance in obese adolescents

Therapeutic Advances in Endocrinology and Metabolism

Volumn 5, Issue 6, 2014, Pages 166-189

  Peterson, Catherine A ^a   Tosh, Aneesh K ^a   Belenchia, Anthony M ^a  

^a University of Missouri   (United States)

Author keywords

adolescent obesity; diabetes; glucose tolerance; hypovitaminosis D; insulin resistance; insulin sensitivity; vitamin D deficiency; vitamin D insufficiency

Indexed keywords

25 HYDROXYVITAMIN D; 7 DEHYDROCHOLESTEROL; ADIPONECTIN; CALCITRIOL; CALCIUM; COLECALCIFEROL; LOW DENSITY LIPOPROTEIN; PARATHYROID HORMONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID X RECEPTOR; VITAMIN D BINDING PROTEIN;

ABDOMINAL OBESITY; ADOLESCENT; B LYMPHOCYTE; CELL FUNCTION; CHILDHOOD OBESITY; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; ENVIRONMENTAL STRESS; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SUNLIGHT; TRANSPORT AT THE CELLULAR LEVEL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D INTOXICATION; VITAMIN D METABOLISM; VITAMIN D RESPONSIVE ELEMENT; VITAMIN SUPPLEMENTATION; VITAMIN TRANSPORTATION; WAIST CIRCUMFERENCE; WORLD HEALTH ORGANIZATION;

EID: 84915810046     PISSN: 20420188     EISSN: 20420196     Source Type: Journal    
DOI: 10.1177/2042018814547205     Document Type: Review

References (165)

1. Alberti K. Eckel R. Grundy S. Zimmet P. Cleeman J. Donato K. et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640–1645.
2. Alemzadeh R. Kichler J. (2012) Parathyroid hormone is associated with biomarkers of insulin resistance and inflammation, independent of vitamin D status, in obese adolescents. Metab Syndr Relat Disord 10: 422–429.
3. Alemzadeh R. Kichler J. Babar G. Calhoun M. (2008) Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism 57: 183–191.
4. Alkharfy K. Al-Daghri N. Yakout S. Hussain T. Mohammed A. Krishnaswamy S. (2013) Influence of vitamin D treatment on transcriptional regulation of insulin-sensitive genes. Metab Syndr Relat Disord 11: 283–288.
5. American Academy of Pediatrics. (2012) Dietary reference intakes for calcium and vitamin D. Pediatrics 130: e1424.
6. Andersen R. Molgaard C. Skovgaard L. Brot C. Cashman K. Chabros E. et al. (2005) Teenage girls and elderly women living in northern Europe have low winter vitamin D status. Eur J Clin Nutr 59: 533–541.
7. Ashraf A. Alvarez J. Gower B. Saenz K. McCormick K. (2011) Associations of serum 25-hydroxyvitamin D and components of the metabolic syndrome in obese adolescent females. Obesity 19: 2214–2221.
8. Ashraf A. Alvarez J. Saenz K. Gower B. McCormick K. Franklin F. (2009) Threshold for effects of vitamin D deficiency on glucose metabolism in obese female African-American adolescents. J Clin Endocrinol Metab 94: 3200–3206.
9. Bailey R. Dodd K. Goldman J. Gahche J. Dwyer J. Moshfegh A. et al. (2010) Estimation of total usual calcium and vitamin D intakes in the United States. J Nutr 140: 817–822.
10. Belenchia A. Tosh A. Hillman L. Peterson C. (2013) Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. Am J Clin Nutr 97: 774–781.
11. Berg A. Combs T. Du X. Brownlee M. Scherer P. (2001) The adipocyte-secreted protein Acrp 30 enhances hepatic insulin action. Nat Med 7: 947–953.
12. Biancuzzo R. Clarke N. Reitz R. Travison T. Holick M. (2013) Serum concentrations of 1,25-dihydroxyvitamin D 2 and 1,25-dihydroxyvitamin D 3 in response to vitamin D 2 and vitamin D 3 supplementation. J Clin Endocrinol Metab 98: 973–979.
13. Bikle D. (2007) What is new in vitamin D: 2006–2007. Curr Opin Rheumatol 19: 383–388.
14. Billaudel B. Delbancut A. Sutter B. Faure A. (1993) Stimulatory effect of 1,25-dihydroxyvitamin D 3 on calcium handling and insulin secretion by islets from vitamin D3-deficient rats. Steroids 58: 335–341.
15. Black L. Jacoby P. She Ping-Delfos W. Mori T. Beilin L. Olynyk J. et al. (2014) Low serum 25-hydroxyvitamin D concentrations associate with non-alcoholic fatty liver disease in adolescents independent of adiposity. J Gastroenterol Hepatol 29: 1215–1222.
16. Blum M. Dolnikowski G. Seyoum E. Harris S. Booth S. Peterson J. et al. (2008) Vitamin D (3) in fat tissue. Endocrine 33: 90–94.
17. Borradale D. Kimlin M. (2009) Vitamin D in health and disease: an insight into traditional functions and new roles for the ‘sunshine vitamin’. Nutr Res Rev 22: 118-136.
18. Braegger C. Campoy C. Colomb V. Decsi T. Domellof M. Fewtrell M. et al. (2013) Vitamin D in the healthy European paediatric population. J Pediatr Gastroenterol Nutr 56: 692–701.
19. Brannon P. Yetley E. Bailey R. Picciano M. (2008) Overview of the conference ‘Vitamin D and Health in the 21st Century: an Update’. Am J Clin Nutr 88: 483S–490S.
20. Buemann B. Sorensen T. Pedersen O. Black E. Holst C. Toubro S. et al. (2005) Lower-body fat mass as an independent marker of insulin sensitivity – the role of adiponectin. Int J Obes 29: 624–631.
21. Buyukinan M. Ozen S. Kokkun S. Saz E. (2012) The relation of vitamin D deficiency with puberty and insulin resistance in obese children and adolescents. J Pediatr Endocrinol Metab 25: 83–87.
22. Calle C. Maestro B. Garcia-Arencibia M. (2008) Genomic actions of 1,25-dihydroxyvitamin D 3 on insulin receptor gene expression, insulin receptor number and insulin activity in the kidney, liver and adipose tissue of streptozotocin-induced diabetic rats. BMC Mol Biol 9: 65.
23. Calvo M. Whiting S. Barton C. (2004) Vitamin D fortification in the United States and Canada: current status and data needs. Am J Clin Nutr 80: 1710S–1716S.
24. Cantorna M. Zhu Y. Froicu M. Wittke A. (2004) Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 80: 1717S–1720S.
25. Castro A. Frederico M. Cazarolli L. Bretanha L. Tavares L. Buss Z. et al. (2014) Betulinic acid and 1,25(OH) (2) vitamin D (3) share intracellular signal transduction in glucose homeostasis in soleus muscle. Int J Biochem Cell Biol 48: 18–27.
26. Ceglia L. (2009) Vitamin D and its role in skeletal muscle. Curr Opin Clin Nutr Metab Care 12: 628–633.
27. Chagas C. Borges M. Martini L. Rogero M. (2012) Focus on vitamin D, inflammation and type 2 diabetes. Nutrients 4: 52–67.
28. Chen Y. Zhang J. Ge X. Du J. Deb D. Li Y. (2013) Vitamin D receptor inhibits nuclear factor kappaB activation by interacting with IkappaB kinase beta protein. J Biol Chem 288: 19450–19458.
29. Chun R. Peercy B. Orwoll E. Nielson C. Adams J. Hewison M. (2013) Vitamin D and DBP: the free hormone hypothesis revisited. J Steroid Biochem Mol Biol pii: S0960-0760 (13)00186-6. doi: 10.1016/j.jsbmb.2013.09.012.
30. Chung S. Lee Y. Hong H. Kang M. Kwon H. Shin C. et al. (2014) Inverse relationship between vitamin D status and insulin resistance and the risk of impaired fasting glucose in Korean children and adolescents: the Korean National Health and Nutrition Examination Survey (KNHANES) 2009–2010. Public Health Nutr 17: 795–802.
31. Codoner-Franch P. Tavarez-Alonso S. Simo-Jorda R. Laporta-Martin P. Carratala-Calvo A. Alonso-Iglesias E. (2012) Vitamin D status is linked to biomarkers of oxidative stress, inflammation, and endothelial activation in obese children. J Pediatr 161: 848–854.
32. Cole T. Bellizzi M. Flegal K. Dietz W. (2000) Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320: 1240–1243.
33. Coupaye M. Breuil M. Riviere P. Castel B. Bogard C. Dupre T. et al. (2013) Serum vitamin D increases with weight loss in obese subjects 6 months after Roux-en-Y gastric bypass. Obes Surg 23: 486–493.
34. Creo A. Rosen J. Ariza A. Hidaka K. Binns H. (2013) Vitamin D levels, insulin resistance, and cardiovascular risks in very young obese children. J Pediatr Endocrinol Metab 26: 97–104.
35. Dabelea D. Mayer-Davis E. Saydah S. Imperatore G. Linder B. Divers J. et al. (2014) Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 311: 1778–1786.
36. de las Heras J. Rajakumar K. Lee S. Bacha F. Holick M. Arslanian S. (2013) 25-Hydroxyvitamin D in obese youth across the spectrum of glucose tolerance from normal to prediabetes to type 2 diabetes. Diabetes Care 36: 2048–2053.
37. de Moraes A. Fadoni R. Ricardi L. Souza T. Rosaneli C. Nakashima A. et al. (2011) Prevalence of abdominal obesity in adolescents: a systematic review. Obes Rev 12: 69–77.
38. Delvin E. Lambert M. Levy E. O'Loughlin J. Mark S. Gray-Donald K. et al. (2010) Vitamin D status is modestly associated with glycemia and indicators of lipid metabolism in French-Canadian children and adolescents. J Nutr 140: 987–991.
39. de Onis M. Onyango A. Borghi E. Siyam A. Nishida C. Siekmann J. (2007) Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 85: 660–667.
40. Diabetes Prevention Program Research Group (2012) The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care 35: 723–730.
41. Ding C. Gao D. Wilding J. Trayhurn P. Bing C. (2012) Vitamin D signalling in adipose tissue. Br J Nutr 108: 1915–1923.
42. Ding C. Wilding J. Bing C. (2013) 1,25-dihydroxyvitamin D 3 protects against macrophage-induced activation of NFkappaB and MAPK signalling and chemokine release in human adipocytes. PloS ONE 8: e61707.
43. Drincic A. Armas L. van Diest E. Heaney R. (2012) Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity 20: 1444–1448.
44. Du T. Zhou Z. You S. Lin J. Yang L. Zhou W. et al. (2009) Regulation by 1, 25-dihydroxy-vitamin D 3 on altered TLRs expression and response to ligands of monocyte from autoimmune diabetes. Clin Chim Acta 402: 133–138.
45. Economos C. Moore C. Hyatt R. Kuder J. Chen T. Meydani S. et al. (2014) Multinutrient-fortified juices improve vitamin D and vitamin E status in children: a randomized controlled trial. J Acad Nutr Diet 114: 709–717.
46. EFSA Panel on Dietetic Products, Nutritition and Allergies (2012) Scientific opinion on the tolerable upper intake level of vitamin D. EFSA J 10: 2813–2857.
47. Erdonmez D. Hatun S. Cizmecioglu F. Keser A. (2011) No relationship between vitamin D status and insulin resistance in a group of high school students. J Clin Res Pediatr Endocrinol 3: 198–201.
48. Erkal M. Wilde J. Bilgin Y. Akinci A. Demir E. Bodeker R. et al. (2006) High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors. Osteoporos Int 17: 1133–1140.
49. Fazeli F. van der Aa M. van der Vorst M. Knibbe C. de Boer A. (2013) Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches. Diabetologia 56: 1471–1488.
50. Flores M. (2005) A role of vitamin D in low-intensity chronic inflammation and insulin resistance in type 2 diabetes mellitus? Nutr Res Rev 18: 175–182.
51. Ganji V. Zhang X. Shaikh N. Tangpricha V. (2011) Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 2001–2006. Am J Clin Nutr 94: 225–233.
52. Garanty-Bogacka B. Syrenicz M. Goral J. Krupa B. Syrenicz J. Walczak M. et al. (2011) Serum 25-hydroxyvitamin D (25-OH-D) in obese adolescents. Endokrynol Pol 62: 506–511.
53. Garland C. Garland F. Gorham E. (2003) Epidemiologic evidence for different roles of ultraviolet A and B radiation in melanoma mortality rates. Ann Epidemiol 13: 395–404.
54. George P. Pearson E. Witham M. (2012) Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet Med 29: e142–e150.
55. Grant W. Holick M. (2005) Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev 10: 94–111.
56. Guillot X. Semerano L. Saidenberg-Kermanac'h N. Falgarone G. Boissier M. (2010) Vitamin D and inflammation. Joint Bone Spine 77: 552–557.
57. Guzel R. Kozanoglu E. Guler-Uysal F. Soyupak S. Sarpel T. (2001) Vitamin D status and bone mineral density of veiled and unveiled Turkish women. J Womens Health Gend Based Med 10: 765–770.
58. Hannon T. Janosky J. Arslanian S. (2006) Longitudinal study of physiologic insulin resistance and metabolic changes of puberty. Pediatr Res 60: 759–763.
59. Harel Z. Cromer B. DiVasta A. Gordon C. (2013) Recommended vitamin D intake and management of low vitamin D status in adolescents: a position statement of the society for adolescent health and medicine. J Adolesc Health 52: 801–803.
60. Harel Z. Flanagan P. Forcier M. Harel D. (2011) Low vitamin D status among obese adolescents: prevalence and response to treatment. J Adolesc Health 48: 448–452.
61. Hathcock J. Shao A. Vieth R. Heaney R. (2007) Risk assessment for vitamin D. Am J Clin Nutr 85: 6–18.
62. Haussler M. Whitfield G. Kaneko I. Haussler C. Hsieh D. Hsieh J. et al. (2013) Molecular mechanisms of vitamin D action. Calcif Tissue Int 92: 77–98.
63. Heaney R. Davies K. Chen T. Holick M. Barger-Lux M. (2003) Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77: 204–210.
64. Heaney R. Horst R. Cullen D. Armas L. (2009) Vitamin D 3 distribution and status in the body. J Am Coll Nutr 28: 252–256.
65. Henry H. Bouillon R. Norman A. Gallagher J. Lips P. Heaney R. et al. (2010) 14th Vitamin D Workshop consensus on vitamin D nutritional guidelines. J Steroid Biochem Mol Biol 121: 4–6.
66. Hillier T. Pedula K. (2003) Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth. Diabetes Care 26: 2999–3005.
67. Holick M. (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80: 1678S–1688S.
68. Holick M. (2006) Vitamin D. In: Ed. Shils M. Shike M. Ross A. Caballero B. Cousins R. (eds), Modern Nutrition in Health and Disease, 10th edn. Baltimore, MD: Lippincott Williams & Wilkins, pp. 376–395.
69. Holick M. (2007) Vitamin D deficiency. N Engl J Med 357: 266–281.
70. Holick M. (2009) Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 19: 73–78.
71. Holick M. Binkley N. Bischoff-Ferrari H. Gordon C. Hanley D. Heaney R. et al. (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96: 1911–1930.
72. Holick M. Jenkins M. (2003) The UV Advantage. New York: ibooks.
73. Hopkins M. Owen J. Ahearn T. Fedirko V. Flanders W. Jones D. et al. (2011) Effects of supplemental vitamin D and calcium on biomarkers of inflammation in colorectal adenoma patients: a randomized, controlled clinical trial. Cancer Prev Res 4: 1645–1654.
74. Huang Y. Ishizuka T. Miura A. Kajita K. Ishizawa M. Kimura M. et al. (2002) Effect of 1 alpha,25-dihydroxy vitamin D 3 and vitamin E on insulin-induced glucose uptake in rat adipocytes. Diabetes Res Clin Pract 55: 175–183.
75. Jang H. Lee H. Park J. Kang J. Song J. (2013) Association between serum vitamin D and metabolic risk factors in Korean schoolgirls. Osong Public Health Res Perspect 4: 179–186.
76. Jimenez-Pavon D. Sese M. Valtuena J. Cuenca-Garcia M. Gonzalez-Gross M. Gottrand F. et al. (2014) Leptin, vitamin D, and cardiorespiratory fitness as risk factors for insulin resistance in European adolescents: gender differences in the HELENA Study. Appl Physiol Nutr Metab 39: 530–537.
77. Jones G. (2008) Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 88: 582S–586S.
78. Kardas F. Kendirci M. Kurtoglu S. (2013) Cardiometabolic risk factors related to vitamin D and adiponectin in obese children and adolescents. Int J Endocrinol 2013: 503270.
79. Kayaniyil S. Harris S. Retnakaran R. Vieth R. Knight J. Gerstein H. et al. (2014) Prospective association of 25(OH)D with metabolic syndrome. Clin Endocrinol 80: 502–507.
80. Keast D. Fulgoni V. III Nicklas T. O'Neil C. (2013) Food sources of energy and nutrients among children in the United States: National Health and Nutrition Examination Survey 2003–2006. Nutrients 5: 283–301.
81. Kelishadi R. Salek S. Salek M. Hashemipour M. Movahedian M. (2014) Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial. J Pediatr 90: 28–34.
82. Kelly A. Brooks L. Dougherty S. Carlow D. Zemel B. (2011) A cross-sectional study of vitamin D and insulin resistance in children. Arch Dis Child 96: 447–452.
83. Kennedy C. Bajdik C. Willemze R. de Gruijl F. Bouwes Bavinck J. (2003) The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. J Invest Dermatol 120: 1087–1093.
84. Khadgawat R. Thomas T. Gahlot M. Tandon N. Tangpricha V. Khandelwal D. et al. (2012) The effect of puberty on interaction between vitamin D status and insulin resistance in obese Asian-Indian children. Int J Endocrinol 2012: 173581.
85. Khan H. Kunutsor S. Franco O. Chowdhury R. (2013) Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies. Proc Nutr Soc 72: 89–97.
86. Kharroubi I. Rasschaert J. Eizirik D. Cnop M. (2003) Expression of adiponectin receptors in pancreatic beta cells. Biochem Biophys Res Commun 312: 1118–1122.
87. Kramer C.K. Swaminathan B. Hanley A.J. Connelly P.W. Sermer M. Zinman B. et al. (2014) Prospective Associations of Vitamin D Status with Beta-cell function, Insulin Sensitivity and Glycemia: The Impact of Parathyroid Hormone Status. Diabetes.
88. Labriji-Mestaghanmi H. Billaudel B. Garnier P. Malaisse W. Sutter B. (1988) Vitamin D and pancreatic islet function. I. Time course for changes in insulin secretion and content during vitamin D deprivation and repletion. J Endocrinol Invest 11: 577–584.
89. LeBlanc E. Perrin N. Johnson J. Jr. Ballatore A. Hillier T. (2013) Over-the-counter and compounded vitamin D: is potency what we expect? JAMA Intern Med 173: 585–586.
90. Lee S. Clark S.A. Gill R.K. Christakos S. (1994) 1,25-Dihydroxyvitamin D 3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion. Endocrinology 134: 1602–1610.
91. Lenders C. Feldman H. Von S. Merewood A. Sweeney C. Wilson D. et al. (2009) Relation of body fat indexes to vitamin D status and deficiency among obese adolescents. Am J Clin Nutr 90: 459–467.
92. Lin E. Armstrong-Moore D. Liang Z. Sweeney J. Torres W. Ziegler T. et al. (2011) Contribution of adipose tissue to plasma 25-hydroxyvitamin D concentrations during weight loss following gastric bypass surgery. Obesity 19: 588–594.
93. Lips P. (2006) Vitamin D physiology. Prog Biophys Mol Biol 92: 4–8.
94. Liu E. Meigs J. Pittas A. McKeown N. Economos C. Booth S. et al. (2009) Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr 139: 329–334.
95. Macdonald H. (2013) Contributions of sunlight and diet to vitamin D status. Calcif Tissue Int 92: 163–176.
96. Maeda N. Takahashi M. Funahashi T. Kihara S. Nishizawa H. Kishida K. et al. (2001) PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50: 2094–2099.
97. Maestro B. Davila N. Carranza M. Calle C. (2003) Identification of a vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol 84: 223–230.
98. Maestro B. Molero S. Bajo S. Davila N. Calle C. (2002) Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D (3). Cell Biochem Funct 20: 227–232.
99. Manna P. Jain S. (2012) Vitamin D up-regulates glucose transporter 4 (GLUT4) translocation and glucose utilization mediated by cystathionine-gamma-lyase (CSE) activation and H2S formation in 3T3L1 adipocytes. J Biol Chem 287: 42324–42332.
100. Marzuillo P. Del Giudice E. Santoro N. (2014) Pediatric non-alcoholic fatty liver disease: New insights and future directions. World J Hepatol 6: 217–225.
101. Mawer E. Backhouse J. Holman C. Lumb G. Stanbury S. (1972) The distribution and storage of vitamin D and its metabolites in human tissues. Clin Sci 43: 413–431.
102. McDonagh M. Selph S. Ozpinar A. Foley C. (2014) Systematic review of the benefits and risks of metformin in treating obesity in children aged 18 years and younger. JAMA Pediatr 168: 178–184.
103. Miller R. Chu Q. Xie J. Foretz M. Viollet B. Birnbaum M. (2013) Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP. Nature 494: 256–260.
104. Misra M. Pacaud D. Petryk A. Collett-Solberg P. Kappy M. (2008) Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 122: 398–417.
105. Mitri J. Dawson-Hughes B. Hu F. Pittas A. (2011) Effects of vitamin D and calcium supplementation on pancreatic beta cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 94: 486–494.
106. Mostofa K. Liu C. Vione D. Gao K. Ogawa H. (2013) Sources, factors, mechanisms and possible solutions to pollutants in marine ecosystems. Environ Pollut 182: 461–478.
107. Motoshima H. Wu X. Sinha M. Hardy V. Rosato E. Barbot D. et al. (2002) Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab 87: 5662–5667.
108. Nam G. Kim do H. Cho K. Park Y. Han K. Choi Y. et al. (2012) Estimate of a predictive cut-off value for serum 25-hydroxyvitamin D reflecting abdominal obesity in Korean adolescents. Nutr Res 32: 395–402.
109. National Heart Forum (2012) Bending the obesity cost curve in California: reducing the average body mass index in the state by 5 percent could lead to health care savings of more then $28 billion in 10 years and $81 billion in 20 years. Issue Brief. Washington DC and Princeton, NJ: Trust for America's Health and Robert Wood Foundation.
110. Ng M. Fleming T. Robinson M. Thomson B. Graetz N. Margono C. et al. (2014) Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet doi:10.1016/S0140-6736 (14)60460-8.
111. Nimitphong H. Chanprasertyothin S. Jongjaroenprasert W. Ongphiphadhanakul B. (2009) The association between vitamin D status and circulating adiponectin independent of adiposity in subjects with abnormal glucose tolerance. Endocrine 36: 205–210.
112. Nsiah-Kumi P. Erickson J. Beals J. Ogle E. Whiting M. Brushbreaker C. et al. (2012) Vitamin D insufficiency is associated with diabetes risk in native American children. Clin Pediatr 51: 146–153.
113. Nunlee-Bland G. Gambhir K. Abrams C. Abdul M. Vahedi M. Odonkor W. (2011) Vitamin D deficiency and insulin resistance in obese African-American adolescents. J Pediatr Endocrinol Metab 24: 29–33.
114. Ogden C. Carroll M. Kit B. Flegal K. (2012) Prevalence of obesity and trends in body mass index among US children and adolescents, 1999–2010. JAMA 307: 483–490.
115. Olson M. Maalouf N. Oden J. White P. Hutchison M. (2012) Vitamin D deficiency in obese children and its relationship to glucose homeostasis. J Clin Endocrinol Metab 97: 279–285.
116. Pacifico L. Anania C. Osborn J. Ferraro F. Bonci E. Olivero E. et al. (2011) Low 25(OH)D3 levels are associated with total adiposity, metabolic syndrome, and hypertension in Caucasian children and adolescents. Eur J Endocrinol 165: 603–611.
117. Parikh S. Guo D. Pollock N. Petty K. Bhagatwala J. Gutin B. et al. (2012) Circulating 25-hydroxyvitamin D concentrations are correlated with cardiometabolic risk among American black and white adolescents living in a year-round sunny climate. Diabetes Care 35: 1133–1138.
118. Park M. Kinra S. Ward K. White B. Viner R. (2009) Metformin for obesity in children and adolescents: a systematic review. Diabetes Care 32: 1743–1745.
119. Park S. Kim D. Kwon D. Yang H. (2011) Long-term central infusion of adiponectin improves energy and glucose homeostasis by decreasing fat storage and suppressing hepatic gluconeogenesis without changing food intake. J Neuroendocrinol 23: 687–698.
120. Pathak K. Soares M. Calton E. Zhao Y. Hallett J. (2014) Vitamin D supplementation and body weight status: a systematic review and meta-analysis of randomized controlled trials. Obes Rev 15: 528–537.
121. Pirgon O. Cekmez F. Bilgin H. Eren E. Dundar B. (2013) Low 25-hydroxyvitamin D level is associated with insulin sensitivity in obese adolescents with non-alcoholic fatty liver disease. Obes Res Clin Pract 7: e275–e283.
122. Pittas A. Lau J. Hu F. Dawson-Hughes B. (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92: 2017–2029.
123. Pludowski P. Karczmarewicz E. Bayer M. Carter G. Chlebna-Sokol D. Czech-Kowalska J. et al. (2013) Practical guidelines for the supplementation of vitamin D and the treatment of deficits in central Europe – recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol 64: 319–327.
124. Ponda M. McGee D. Breslow J. (2014) Vitamin D binding protein levels do not influence the effect of vitamin D repletion on serum PTH and calcium: data from a randomized, controlled trial. J Clin Endocrinol Metab 99: 2494–2499.
125. Poomthavorn P. Saowan S. Mahachoklertwattana P. Chailurkit L. Khlairit P. (2012) Vitamin D status and glucose homeostasis in obese children and adolescents living in the tropics. Int J Obes 36: 491–495.
126. Prentice A. (2008) Vitamin D deficiency: a global perspective. Nutr Rev 66: S153–S164.
127. Punthakee Z. Delvin E. O'Loughlin J. Paradis G. Levy E. Platt R. et al. (2006) Adiponectin, adiposity, and insulin resistance in children and adolescents. J Clin Endocrinol Metab 91: 2119–2125.
128. Rajakumar K. de Las H. Lee S. Holick M. Arslanian S. (2012) 25-hydroxyvitamin D concentrations and in vivo insulin sensitivity and beta-cell function relative to insulin sensitivity in black and white youth. Diabetes Care 35: 627–633.
129. Rajakumar K. Reis E. Holick M. (2013) Dosing error with over-the-counter vitamin D supplement: a risk for vitamin D toxicity in infants. Clin Pediatr 52: 82–85.
130. Reinehr T. de Sousa G. Alexy U. Kersting M. Andler W. (2007) Vitamin D status and parathyroid hormone in obese children before and after weight loss. Eur J Endocrinol 157: 225–232.
131. Rodbard H. (2008) Diabetes screening, diagnosis, and therapy in pediatric patients with type 2 diabetes. Medscape J Med 10: 184
132. Rosenstreich S. Rich C. Volwiler W. (1971) Deposition in and release of vitamin D 3 from body fat: evidence for a storage site in the rat. J Clin Invest 50: 679–687.
133. Ross A. (2011) The 2011 report on dietary reference intakes for calcium and vitamin D. Public Health Nutr 14: 938–939.
134. Roth C. Elfers C. Kratz M. Hoofnagle A. (2011) Vitamin d deficiency in obese children and its relationship to insulin resistance and adipokines. J Obes 2011: 495101.
135. Schmid A. Walther B. (2013) Natural vitamin D content in animal products. Adv Nutr 4: 453–462.
136. Shab-Bidar S. Neyestani T. Djazayery A. Eshraghian M. Houshiarrad A. Kalayi A. et al. (2012) Improvement of vitamin D status resulted in amelioration of biomarkers of systemic inflammation in the subjects with type 2 diabetes. Diabetes Metab Res Rev 28: 424–430.
137. Shin Y. Shin H. Lee Y. (2013) Vitamin D status and childhood health. Korean J Pediatr 56: 417–423.
138. Sinha R. Fisch G. Teague B. Tamborlane W. Banyas B. Allen K. et al. (2002) Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346: 802–810.
139. Skinner A. Skelton J. (2014) Prevalence and trends in obesity and severe obesity among children in the United States, 1999–2012. JAMA Pediatr 168: 561–566.
140. Souberbielle J. Courbebaisse M. Cormier C. Pierrot-Deseilligny C. Viard J. Jean G. et al. (2012) When should we measure vitamin D concentration in clinical practice? Scand J Clin Lab Invest 243(Suppl.): 129–135.
141. Speeckaert R. van Gele M. Speeckaert M. Lambert J. van Geel N. (2014) The biology of hyperpigmentation syndromes. Pigment Cell Melanoma Res 27: 512–524.
142. Stanley T. Bredella M. Pierce L. Misra M. (2013) The ratio of parathyroid hormone to vitamin D is a determinant of cardiovascular risk and insulin sensitivity in adolescent girls. Metab Syndr Relat Disord 11: 56–62.
143. Stoffman N. Gordon C. (2009) Vitamin D and adolescents: what do we know? Curr Opin Pediatr 21: 465–471.
144. Tangpricha V. Koutkia P. Rieke S. Chen T. Perez A. Holick M. (2003) Fortification of orange juice with vitamin D: a novel approach for enhancing vitamin D nutritional health. Am J Clin Nutr 77: 1478–1483.
145. Tangpricha V. Turner A. Spina C. Decastro S. Chen T. Holick M. (2004) Tanning is associated with optimal vitamin D status (serum 25-hydroxyvitamin D concentration) and higher bone mineral density. Am J Clin Nutr 80: 1645–1649.
146. Terenetskaya I. (2004) Two methods for direct assessment of the vitamin D synthetic capacity of sunlight and artificial UV sources. J Steroid Biochem Mol Biol 89–90: 623–626.
147. Torun E. Gonullu E. Ozgen I. Cindemir E. Oktem F. (2013) Vitamin D deficiency and insufficiency in obese children and adolescents and its relationship with insulin resistance. Int J Endocrinol 2013: 631845.
148. Travers S. Jeffers B. Bloch C. Hill J. Eckel R. (1995) Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children. J Clin Endocrinol Metab 80: 172–178.
149. Tripkovic L. Lambert H. Hart K. Smith C. Bucca G. Penson S. et al. (2012) Comparison of vitamin D 2 and vitamin D 3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr 95: 1357–1364.
150. Tuohimaa P. Wang J. Khan S. Kuuslahti M. Qian K. Manninen T. et al. (2013) Gene expression profiles in human and mouse primary cells provide new insights into the differential actions of vitamin D 3 metabolites. PloS ONE 8: e75338.
151. Turer C. Lin H. Flores G. (2013) Prevalence of vitamin D deficiency among overweight and obese US children. Pediatrics 131: e152–e161.
152. van Schoor N. Lips P. (2011) Worldwide vitamin D status. Best Pract Res Clin Endocrinol Metab 25: 671–680.
153. Vimaleswaran K. Berry D. Lu C. Tikkanen E. Pilz S. Hiraki L. et al. (2013) Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 10: e1001383.
154. Viner R. Segal T. Lichtarowicz-Krynska E. Hindmarsh P. (2005) Prevalence of the insulin resistance syndrome in obesity. Arch Dis Child 90: 10–14.
155. Walker G. Ricotti R. Roccio M. Moia S. Bellone S. Prodam F. et al. (2014) Pediatric obesity and vitamin D deficiency: a proteomic approach identifies multimeric adiponectin as a key link between these conditions. PloS ONE 9: e83685.
156. Wamberg L. Cullberg K. Rejnmark L. Richelsen B. Pedersen S. (2013) Investigations of the anti-inflammatory effects of vitamin D in adipose tissue: results from an in vitro study and a randomized controlled trial. Horm Metab Res 45: 456–462.
157. Wang Y. Zhu J. DeLuca H. (2012) Where is the vitamin D receptor? Arch Biochem Biophys 523: 123–133.
158. Webb A. Engelsen O. (2006) Calculated ultraviolet exposure levels for a healthy vitamin D status. Photochem Photobiol 82: 1697–1703.
159. Witteveen J. van, Thiel S. Romijn J. Hamdy N. (2013) Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature. Eur J Endocrinol 168: R45–R53.
160. Wolden-Kirk H. Overbergh L. Gysemans C. Brusgaard K. Naamane N. van L.L. et al. (2013) Unraveling the effects of 1,25OH2D3 on global gene expression in pancreatic islets. J Steroid Biochem Mol Biol 136: 68–79.
161. Wortsman J. Matsuoka L. Chen T. Lu Z. Holick M. (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72: 690–693.
162. Wu F. Staykova T. Horne A. Clearwater J. Ames R. Mason B. et al. (2003) Efficacy of an oral, 10-day course of high-dose calciferol in correcting vitamin D deficiency. N Z Med J 116: U536.
163. Zabihiyeganeh M. Jahed A. Nojomi M. (2013) Treatment of hypovitaminosis D with pharmacologic doses of cholecalciferol, oral vs intramuscular; an open labeled RCT. Clin Endocrinol 78: 210–216.
164. Zeitz U. Weber K. Soegiarto D. Wolf E. Balling R. Erben R. (2003) Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J 17: 509–511.
165. Zimmet P. Alberti K. Kaufman F. Tajima N. Silink M. Arslanian S. et al. (2007) The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes 8: 299–306.